Literature DB >> 28810142

Control of Metastasis by NK Cells.

Alejandro López-Soto1, Segundo Gonzalez2, Mark J Smyth3, Lorenzo Galluzzi4.   

Abstract

The metastatic spread of malignant cells to distant anatomical locations is a prominent cause of cancer-related death. Metastasis is governed by cancer-cell-intrinsic mechanisms that enable neoplastic cells to invade the local microenvironment, reach the circulation, and colonize distant sites, including the so-called epithelial-to-mesenchymal transition. Moreover, metastasis is regulated by microenvironmental and systemic processes, such as immunosurveillance. Here, we outline the cancer-cell-intrinsic and -extrinsic factors that regulate metastasis, discuss the key role of natural killer (NK) cells in the control of metastatic dissemination, and present potential therapeutic approaches to prevent or target metastatic disease by harnessing NK cells.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADCC; CTLA4; DNAM-1; NKG2D; PD-1; TGFB1; circulating tumor cells; disseminated tumor cells; immune checkpoint blockers; metastatic cascade

Mesh:

Year:  2017        PMID: 28810142     DOI: 10.1016/j.ccell.2017.06.009

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  224 in total

1.  Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers.

Authors:  Ian MacFawn; Hannah Wilson; Luke A Selth; Ian Leighton; Ilya Serebriiskii; R Christopher Bleackley; Osama Elzamzamy; Joshua Farris; Phillip M Pifer; Jennifer Richer; Steven M Frisch
Journal:  Mol Immunol       Date:  2018-11-30       Impact factor: 4.407

2.  3D bioprinting for oncology applications.

Authors:  Tingting Liu; Clement Delavaux; Yu Shrike Zhang
Journal:  J 3D Print Med       Date:  2019-05-30

Review 3.  Trial Watch: Toll-like receptor agonists in cancer immunotherapy.

Authors:  Melody Smith; Elena García-Martínez; Michael R Pitter; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-10-11       Impact factor: 8.110

Review 4.  Steps in metastasis: an updated review.

Authors:  Jamal Majidpoor; Keywan Mortezaee
Journal:  Med Oncol       Date:  2021-01-04       Impact factor: 3.064

Review 5.  Metastatic niche functions and therapeutic opportunities.

Authors:  Toni Celià-Terrassa; Yibin Kang
Journal:  Nat Cell Biol       Date:  2018-07-26       Impact factor: 28.824

6.  Rapid expansion in the WAVE bioreactor of clinical scale cells for tumor immunotherapy.

Authors:  Yiming Meng; Jing Sun; Tingting Hu; Yushu Ma; Tiaozhao Du; Cuicui Kong; Guirong Zhang; Tao Yu; Haozhe Piao
Journal:  Hum Vaccin Immunother       Date:  2018-06-28       Impact factor: 3.452

Review 7.  Innate and acquired immune surveillance in the postdissemination phase of metastasis.

Authors:  Hugo Gonzalez; Isabella Robles; Zena Werb
Journal:  FEBS J       Date:  2017-11-24       Impact factor: 5.542

Review 8.  Trial Watch: Adoptively transferred cells for anticancer immunotherapy.

Authors:  Carole Fournier; François Martin; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi; Lionel Apetoh
Journal:  Oncoimmunology       Date:  2017-08-11       Impact factor: 8.110

9.  The expanding constellation of immune checkpoints: a DNAMic control by CD155.

Authors:  Vincenzo Bronte
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

10.  CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity.

Authors:  Amelia Roman Aguilera; Viviana P Lutzky; Deepak Mittal; Xian-Yang Li; Kimberley Stannard; Kazuyoshi Takeda; Günter Bernhardt; Michele W L Teng; William C Dougall; Mark J Smyth
Journal:  Oncoimmunology       Date:  2018-02-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.